Epidemics caused by dangerous pathogens such as Ebola virus can occur without warning. The administration of protective antibodies against a pathogen is one approach to save lives and reduce the number of victims. How can they be produced quickly and in large quantities in the event of outbreaks? Researchers at the Paul-EhrlichInstitut with scientists at DZIF (German Center for Infection Research) have shown that adjuvanted virus-like particles (VLPs) could be used as a plug-and-play system to rapidly generate functional antibodies in animals that could then be used to treat infected individuals. The results are reported in the online edition of npj Vaccines on 05.10.2018.
Outbreaks of infectious diseases can sometimes reach epidemic proportions, such as the large Ebola virus outbreak in Western Africa in 2014, which resulted in more than 28,500 infections and 11,000 deaths.
A new Ebola outbreak in the Democratic Republic of the Congo is currently being fought. Nipah and Hendra viruses are examples of other dangerous pathogens, which have thus far caused only minor outbreaks, such as the Nipah outbreak ongoing in India.
Effective vaccines against known pathogens have been available for many years. However, in the event of an outbreak with new life-threatening pathogens, therapeutics are needed that can be produced very quickly for many people and provide protection until a vaccine becomes available. Passive immunisation, the administration of convalescent plasma containing specific functional antibodies, provides a straight forward way to treat infected individuals.
Here one makes use of the fact that during an infection, antibodies are produced by the immune system and then circulate in the blood of the convalescent patient. The convalescents' blood plasma, which contains sufficient levels of neutralising antibodies against the specific pathogen, can then be administered to newly infected patients and protect them from disease, or at least prevent severe outcomes.
However, convalescent plasma is often scarce, since only individuals who have already recovered from the disease can serve as donors. Here the production of hyperimmune sera in animals constitutes an attractive alternative. Researchers at Paul Ehrlich Institute led by Prof. Veronika von Messling, Director of the Division of Veterinary Medicine, have collaborated with researchers from the Universities of Marburg and Munich as part of the German Center for Infection Research (DZIF) using Ebola and Nipah viruses as models to investigate how the production of functional antibodies in rabbits can be induced as effectively as possible.
The researchers found that adjuvanted virus-like particles (VLPs) efficiently stimulated the production of functional antibodies at high titers in animals. VLP-based vaccines are particularly interesting because the immune system recognises them as virus particles, but VLPs do not multiply in target cells.
The high antibody titres observed here indicate that de novo antigen expression is less important for the production of functional antibodies than the presentation of the antigen in its natural form. With an optimised purification process, concentrated polyclonal antibodies were obtained that were stable in vivo.
Such polyclonal antibody concentrates have the advantage to be directed against different sites (epitopes) of the pathogen, so there is less risk of loss of function due to mutations in the virus compared to monoclonal antibodies which are directed against only one epitope.
Nipah VLPs were also able to induce the production of high-titre functional antibodies. VLPs can be produced in sufficient quantities for the immunisation of animals within one to two weeks, and can be produced for different pathogens, so that they could potentially be used as a convenient plug-and-play system for antibody production.
"We consider the production of polyclonal antibodies using pathogen-adapted adjuvanted VLPs a promising approach for the rapid delivery of protective immune sera in the event of outbreaks of new dangerous viruses", says Dr. Veronika von Messling in explaining the research team’s results.
Phone: +49 6103 77 1030
SchmidtR, Beltzig LC, Sawatsky B, Dolnik O, Dietzel E,
Krähling V, Volz A, Sutter G, Becker S, von Messling V (2018): Generation of therapeutic antisera for emerging viral infections. NPJ Vaccines. 2018 Okt
NPJ Vaccines 3, Article number: 42 (2018) https://doi.org/10.1038/s41541-018-0082-4
Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft
Solving the efficiency of Gram-negative bacteria
22.03.2019 | Harvard University
Bacteria bide their time when antibiotics attack
22.03.2019 | Rice University
DESY and MPSD scientists create high-order harmonics from solids with controlled polarization states, taking advantage of both crystal symmetry and attosecond electronic dynamics. The newly demonstrated technique might find intriguing applications in petahertz electronics and for spectroscopic studies of novel quantum materials.
The nonlinear process of high-order harmonic generation (HHG) in gases is one of the cornerstones of attosecond science (an attosecond is a billionth of a...
Nano- and microtechnology are promising candidates not only for medical applications such as drug delivery but also for the creation of little robots or flexible integrated sensors. Scientists from the Max Planck Institute for Polymer Research (MPI-P) have created magnetic microparticles, with a newly developed method, that could pave the way for building micro-motors or guiding drugs in the human body to a target, like a tumor. The preparation of such structures as well as their remote-control can be regulated using magnetic fields and therefore can find application in an array of domains.
The magnetic properties of a material control how this material responds to the presence of a magnetic field. Iron oxide is the main component of rust but also...
Due to the special arrangement of its molecules, a new coating made of corn starch is able to repair small scratches by itself through heat: The cross-linking via ring-shaped molecules makes the material mobile, so that it compensates for the scratches and these disappear again.
Superficial micro-scratches on the car body or on other high-gloss surfaces are harmless, but annoying. Especially in the luxury segment such surfaces are...
The Potsdam Echelle Polarimetric and Spectroscopic Instrument (PEPSI) at the Large Binocular Telescope (LBT) in Arizona released its first image of the surface magnetic field of another star. In a paper in the European journal Astronomy & Astrophysics, the PEPSI team presents a Zeeman- Doppler-Image of the surface of the magnetically active star II Pegasi.
A special technique allows astronomers to resolve the surfaces of faraway stars. Those are otherwise only seen as point sources, even in the largest telescopes...
Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have proposed a way to create a completely new source of radiation. Ultra-intense light pulses consist of the motion of a single wave and can be described as a tsunami of light. The strong wave can be used to study interactions between matter and light in a unique way. Their research is now published in the scientific journal Physical Review Letters.
"This source of radiation lets us look at reality through a new angle - it is like twisting a mirror and discovering something completely different," says...
11.03.2019 | Event News
01.03.2019 | Event News
28.02.2019 | Event News
22.03.2019 | Life Sciences
22.03.2019 | Life Sciences
22.03.2019 | Information Technology